{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:09Z","timestamp":1792800009954,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"crossref","award":["ZYLX202137"],"award-info":[{"award-number":["ZYLX202137"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Chaoyang Hospital Science and Technology Innovation Fund","award":["22kcjjzd-7"],"award-info":[{"award-number":["22kcjjzd-7"]}],"id":[{"id":"https:\/\/ror.org\/01eff5662","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00719-2","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T04:28:25Z","timestamp":1747628905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic value of the expression of CD27 and CD117 in newly diagnosed multiple myeloma patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Xu","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-8745","authenticated-orcid":false,"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"9","key":"719_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41408-020-00359-2","volume":"10","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J. 2020;10(9):94.","journal-title":"Blood Cancer J"},{"issue":"6","key":"719_CR2","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/bjh.16488","volume":"189","author":"R Chakraborty","year":"2020","unstructured":"Chakraborty R, Rybicki L, Nakashima MO, et al. Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma. Br J Haematol. 2020;189(6):1074\u201382.","journal-title":"Br J Haematol"},{"issue":"12","key":"719_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41408-018-0155-7","volume":"8","author":"SZ Usmani","year":"2018","unstructured":"Usmani SZ, Hoering A, Cavo M, et al. Clinical predictors of Long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG research project. Blood Cancer J. 2018;8(12):123.","journal-title":"Blood Cancer J"},{"key":"719_CR4","doi-asserted-by":"publisher","first-page":"117822421986823","DOI":"10.1177\/1178224219868235","volume":"13","author":"SA Bird","year":"2019","unstructured":"Bird SA, Boyd K. Multiple myeloma: an overview of management. Palliat Care Social Pract. 2019;13:1178224219868235.","journal-title":"Palliat Care Social Pract"},{"issue":"2","key":"719_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/bjh.14780","volume":"179","author":"P Moreau","year":"2017","unstructured":"Moreau P, de Wit E. Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions. Br J Haematol. 2017;179(2):198\u2013218.","journal-title":"Br J Haematol"},{"issue":"2","key":"719_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bjh.14213","volume":"175","author":"K Yong","year":"2016","unstructured":"Yong K, Delforge M, Driessen C, et al. Multiple myeloma: patient outcomes in real-world practice. Br J Haematol. 2016;175(2):252\u201364.","journal-title":"Br J Haematol"},{"issue":"4","key":"719_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cyto.b.20512","volume":"78","author":"B Paiva","year":"2010","unstructured":"Paiva B, Almeida J, P\u00e9rez-Andr\u00e9s M, et al. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma Cell-related disorders. Cytometry B. 2010;78(4):239\u201352.","journal-title":"Cytometry B"},{"key":"719_CR8","volume-title":"Leukemia","author":"W Li","year":"2022","unstructured":"Li W. In: Leukemia. Li W, editor. Flow cytometry in the diagnosis of Leukemias[M\/OL]. Brisbane: Exon Publications; 2022."},{"issue":"3","key":"719_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3324\/haematol.11080","volume":"93","author":"AC Rawstron","year":"2008","unstructured":"Rawstron AC, Orfao A, Beksac M, et al. Report of the European myeloma network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93(3):431\u20138.","journal-title":"Haematologica"},{"issue":"16","key":"719_CR10","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1200\/JCO.2007.15.4120","volume":"26","author":"G Mateo","year":"2008","unstructured":"Mateo G, Montalb\u00e1n MA, Vidriales M-B, et al. Prognostic value of immunophenotyping in multiple myeloma: A study by the PETHEMA\/GEM cooperative study groups on patients uniformly treated with High-Dose therapy. J Clin Oncol. 2008;26(16):2737\u201344.","journal-title":"J Clin Oncol"},{"key":"719_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.leukres.2015.11.003","volume":"40","author":"Y Pan","year":"2016","unstructured":"Pan Y, Wang H, Tao Q, et al. Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma. Leuk Res. 2016;40:77\u201382.","journal-title":"Leuk Res"},{"issue":"4","key":"719_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/leu.2017.320","volume":"32","author":"P Arana","year":"2018","unstructured":"Arana P, Paiva B, Cedena M-T, et al. Prognostic value of antigen expression in multiple myeloma: A PETHEMA\/GEM study on 1265 patients enrolled in four consecutive clinical trials. Leukemia. 2018;32(4):971\u20138.","journal-title":"Leukemia"},{"key":"719_CR13","doi-asserted-by":"crossref","unstructured":"Zheng D, Zhu M, Li Q et al. Dual negativity of CD56 and CD117 links to unfavorable cytogenetic abnormalities and predicts poor prognosis in multiple myeloma. J Clin Med. 2022;11(21):6524.","DOI":"10.3390\/jcm11216524"},{"issue":"2","key":"719_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1365-2141.2005.05849.x","volume":"132","author":"P Moreau","year":"2006","unstructured":"Moreau P, Robillard N, J\u00e9go G, et al. Lack of CD27 in myeloma delineates different presentation and outcome. Br J Haematol. 2006;132(2):168\u201370.","journal-title":"Br J Haematol"},{"issue":"2","key":"719_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1046\/j.1365-2141.2003.04069.x","volume":"120","author":"Y Katayama","year":"2003","unstructured":"Katayama Y, Sakai A, Oue N, et al. A possible role for the loss of CD27\u2013CD70 interaction in myelomagenesis. Br J Haematol. 2003;120(2):223\u201334.","journal-title":"Br J Haematol"},{"issue":"3","key":"719_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","volume":"13","author":"M Miettinen","year":"2005","unstructured":"Miettinen M, Lasota J. KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphology: AIMM. 2005;13(3):205\u201320.","journal-title":"Appl Immunohistochem Mol Morphology: AIMM"},{"key":"719_CR17","doi-asserted-by":"crossref","unstructured":"Robillard N, Wuill\u00e3me S, Moreau P et al. Immunophenotype of normal and myelomatous Plasma-Cell Subsets[J\/OL]. Front Immunol. 2014;5:137.","DOI":"10.3389\/fimmu.2014.00137"},{"issue":"8","key":"719_CR18","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, et al. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328\u201346.","journal-title":"Lancet Oncol"},{"issue":"8","key":"719_CR19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","volume":"97","author":"FM Ross","year":"2012","unstructured":"Ross FM, Avet-Loiseau H, Ameye G, et al. Report from the European myeloma network on interphase FISH in multiple myeloma and related disorders. Haematologica. 2012;97(8):1272\u20137.","journal-title":"Haematologica"},{"issue":"9","key":"719_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41408-022-00731-4","volume":"12","author":"P Yang","year":"2022","unstructured":"Yang P, Zhou F, Dong Y, et al. The prognostic value of the MASS in a Multi-center cohort of patients with newly diagnosed multiple myeloma. Blood Cancer J. 2022;12(9):134.","journal-title":"Blood Cancer J"},{"issue":"3","key":"719_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ejh.13897","volume":"110","author":"H Chen","year":"2023","unstructured":"Chen H, Shi H, Zhou N, et al. Evaluation of the Mayo additive staging system in patients with newly diagnosed multiple myeloma: A real-world analysis. Eur J Haematol. 2023;110(3):229\u201335.","journal-title":"Eur J Haematol"},{"issue":"10","key":"719_CR22","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/leu.2017.29","volume":"31","author":"J Flores-Montero","year":"2017","unstructured":"Flores-Montero J, Sanoja-Flores L, Paiva B, et al. Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31(10):2094\u2013103.","journal-title":"Leukemia"},{"issue":"1","key":"719_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/bjh.17713","volume":"195","author":"R Bezdekova","year":"2021","unstructured":"Bezdekova R, Jelinek T, Kralova R, et al. Necessity of flow cytometry assessment of Circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia. Br J Haematol. 2021;195(1):95\u2013107.","journal-title":"Br J Haematol"},{"issue":"24","key":"719_CR24","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","volume":"127","author":"P Sonneveld","year":"2016","unstructured":"Sonneveld P, Avet-Loiseau H, Lonial S, et al. Treatment of multiple myeloma with High-risk cytogenetics: A consensus of the international myeloma working group. Blood. 2016;127(24):2955\u201362.","journal-title":"Blood"},{"issue":"3","key":"719_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.beha.2010.09.002","volume":"23","author":"S Kumar","year":"2010","unstructured":"Kumar S, Kimlinger T, Morice W. Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol. 2010;23(3):433\u201351.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"719_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3324\/haematol.2010.031872","volume":"96","author":"M Schmidt-Hieber","year":"2011","unstructured":"Schmidt-Hieber M, P\u00e9rez-Andr\u00e9s M, Paiva B, et al. CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features. Haematologica. 2011;96(2):328\u201332.","journal-title":"Haematologica"},{"key":"719_CR27","doi-asserted-by":"publisher","first-page":"108363","DOI":"10.1016\/j.clim.2020.108363","volume":"213","author":"B Chu","year":"2020","unstructured":"Chu B, Bao L, Wang Y, et al. CD27 antigen negative expression indicates poor prognosis in newly diagnosed multiple myeloma. Clin Immunol (Orlando Fla). 2020;213:108363.","journal-title":"Clin Immunol (Orlando Fla)"},{"issue":"3","key":"719_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1309\/AJCP63TOCFNAMDMS","volume":"137","author":"E Cannizzo","year":"2012","unstructured":"Cannizzo E, Carulli G, Del Vecchio L, et al. The role of CD19 and CD27 in the diagnosis of multiple myeloma by flow cytometry: A new statistical model. Am J Clin Pathol. 2012;137(3):377\u201386.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"719_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3346\/jkms.2013.28.4.542","volume":"28","author":"Y-U Cho","year":"2013","unstructured":"Cho Y-U, Park C-J, Park S-J, et al. Immunophenotypic characterization and quantification of neoplastic bone marrow plasma cells by multiparametric flow cytometry and its clinical significance in Korean myeloma patients. J Korean Med Sci. 2013;28(4):542.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"719_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12885-024-11945-z","volume":"24","author":"X Wang","year":"2024","unstructured":"Wang X, Luo K, Xu Q, et al. Prognostic marker CD27 and its Micro-environmental in multiple myeloma. BMC Cancer. 2024;24(1):352.","journal-title":"BMC Cancer"},{"issue":"12","key":"719_CR31","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1002\/cam4.1840","volume":"7","author":"F Chen","year":"2018","unstructured":"Chen F, Hu Y, Wang X, et al. Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis. Cancer Med. 2018;7(12):5920\u20137.","journal-title":"Cancer Med"},{"issue":"11","key":"719_CR32","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/leu.2015.209","volume":"29","author":"SZ Usmani","year":"2015","unstructured":"Usmani SZ, Rodriguez-Otero P, Bhutani M, et al. Defining and treating High-risk multiple myeloma. Leukemia. 2015;29(11):2119\u201325.","journal-title":"Leukemia"},{"issue":"7","key":"719_CR33","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3324\/haematol.2009.016436","volume":"95","author":"K Neben","year":"2010","unstructured":"Neben K, Jauch A, Bertsch U, et al. Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the international staging system classification allows stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica. 2010;95(7):1150\u20137.","journal-title":"Haematologica"},{"issue":"2","key":"719_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/leu.2011.204","volume":"26","author":"KD Boyd","year":"2012","unstructured":"Boyd KD, Ross FM, Chiecchio L, et al. A novel prognostic model in myeloma based on Co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC myeloma IX trial. Leukemia. 2012;26(2):349\u201355.","journal-title":"Leukemia"},{"issue":"2","key":"719_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2024.01.011","volume":"57","author":"CA Jaeger-Ruckstuhl","year":"2024","unstructured":"Jaeger-Ruckstuhl CA, Lo Y, Fulton E, et al. Signaling via a CD27-TRAF2-SHP-1 axis during Naive T cell activation promotes memory-associated gene regulatory networks. Immunity. 2024;57(2):287\u2013e30212.","journal-title":"Immunity"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00719-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T04:28:29Z","timestamp":1747628909000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00719-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00719-2","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Beijing Chaoyang Hospital\u2019s ethical committee (2022-ke-48).The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Beijing Chaoyang Hospital (no. 2022-ke-48), with the need for written informed consent waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}